Blank, A., Meier, K., Urban, S., Haefeli, W. E., & Weiß, J. (2018). Drug-drug interaction potential of the HBV and HDV entry inhibitor myrcludex B assessed in vitro. Antiviral therapy, 23(3), . https://doi.org/10.3851/IMP3206
Chicago Style (17th ed.) CitationBlank, Antje, Katrin Meier, Stephan Urban, Walter E. Haefeli, and Johanna Weiß. "Drug-drug Interaction Potential of the HBV and HDV Entry Inhibitor Myrcludex B Assessed in Vitro." Antiviral Therapy 23, no. 3 (2018). https://doi.org/10.3851/IMP3206.
MLA (9th ed.) CitationBlank, Antje, et al. "Drug-drug Interaction Potential of the HBV and HDV Entry Inhibitor Myrcludex B Assessed in Vitro." Antiviral Therapy, vol. 23, no. 3, 2018, https://doi.org/10.3851/IMP3206.
Warning: These citations may not always be 100% accurate.